Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Vella

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Molecules (Basel, Switzerland)|February 13, 2025
Characterization of Pure Ozonides from Ozonolysis of Oleic Acid Methyl Ester; Use of a Protocol for the Analysis of the Corresponding Stable Ozonides from Triolein and Organic Extra Virgin Olive Oil (+OIL<sup>®</sup>)Serena Vella, Marina DellaGreca, Angela Tuzi, et al.
PPAR Research|November 2, 2016
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsSerena Vella, Pier Giulio Conaldi, Tullio Florio, et al.
International Journal of Cancer|May 11, 2011
Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cellsSerena Vella, Matteo Conti, Roberta Tasso, et al.
Molecules (Basel, Switzerland)|April 30, 2021
A One-Pot Approach to Novel Pyridazine <i>C</i>-NucleosidesFlavio Cermola, Serena Vella, Marina DellaGreca, et al.
Journal of Neurochemistry|September 22, 2011
Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNAPaola Gavazzo, Serena Vella, Carla Marchetti, et al.
International Journal of Molecular Sciences|October 22, 2011
Selection of candidate housekeeping genes for normalization in human postmortem brain samplesIlaria Penna, Serena Vella, Arianna Gigoni, et al.
Pharmacogenomics|November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patientsClaudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcomaClaudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Open Medicine (Warsaw, Poland)|February 23, 2026
Observational retrospective study on neonatal umbilical cord care: OZOILE on cord separation time and other clinical complicationsGianfranco Scarpelli, Domenico Montesano, Serena Vella, et al.
Biotechnology and Bioengineering|August 24, 2022
NMR as powerful technology for noninvasively monitoring cell health and expansion during bioprocessingFrancesca Benevelli, Serena Vella, Chiara Crosta, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|February 13, 2025
Characterization of Pure Ozonides from Ozonolysis of Oleic Acid Methyl Ester; Use of a Protocol for the Analysis of the Corresponding Stable Ozonides from Triolein and Organic Extra Virgin Olive Oil (+OIL<sup>®</sup>)Serena Vella, Marina DellaGreca, Angela Tuzi, et al.
PPAR Research|November 2, 2016
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsSerena Vella, Pier Giulio Conaldi, Tullio Florio, et al.
International Journal of Cancer|May 11, 2011
Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cellsSerena Vella, Matteo Conti, Roberta Tasso, et al.
Molecules (Basel, Switzerland)|April 30, 2021
A One-Pot Approach to Novel Pyridazine <i>C</i>-NucleosidesFlavio Cermola, Serena Vella, Marina DellaGreca, et al.
Journal of Neurochemistry|September 22, 2011
Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNAPaola Gavazzo, Serena Vella, Carla Marchetti, et al.
International Journal of Molecular Sciences|October 22, 2011
Selection of candidate housekeeping genes for normalization in human postmortem brain samplesIlaria Penna, Serena Vella, Arianna Gigoni, et al.
Pharmacogenomics|November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patientsClaudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcomaClaudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Open Medicine (Warsaw, Poland)|February 23, 2026
Observational retrospective study on neonatal umbilical cord care: OZOILE on cord separation time and other clinical complicationsGianfranco Scarpelli, Domenico Montesano, Serena Vella, et al.
Biotechnology and Bioengineering|August 24, 2022
NMR as powerful technology for noninvasively monitoring cell health and expansion during bioprocessingFrancesca Benevelli, Serena Vella, Chiara Crosta, et al.
Pageof 4